202 related articles for article (PubMed ID: 12502885)
1. A live, attenuated dengue virus type 1 vaccine candidate with a 30-nucleotide deletion in the 3' untranslated region is highly attenuated and immunogenic in monkeys.
Whitehead SS; Falgout B; Hanley KA; Blaney JE; Markoff L; Murphy BR
J Virol; 2003 Jan; 77(2):1653-7. PubMed ID: 12502885
[TBL] [Abstract][Full Text] [Related]
2. Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys.
Blaney JE; Matro JM; Murphy BR; Whitehead SS
J Virol; 2005 May; 79(9):5516-28. PubMed ID: 15827166
[TBL] [Abstract][Full Text] [Related]
3. Introduction of mutations into the non-structural genes or 3' untranslated region of an attenuated dengue virus type 4 vaccine candidate further decreases replication in rhesus monkeys while retaining protective immunity.
Hanley KA; Manlucu LR; Manipon GG; Hanson CT; Whitehead SS; Murphy BR; Blaney JE
Vaccine; 2004 Sep; 22(25-26):3440-8. PubMed ID: 15308370
[TBL] [Abstract][Full Text] [Related]
4. Vaccine candidates for dengue virus type 1 (DEN1) generated by replacement of the structural genes of rDEN4 and rDEN4Delta30 with those of DEN1.
Blaney JE; Sathe NS; Hanson CT; Firestone CY; Murphy BR; Whitehead SS
Virol J; 2007 Feb; 4():23. PubMed ID: 17328799
[TBL] [Abstract][Full Text] [Related]
5. Tick-borne Langat/mosquito-borne dengue flavivirus chimera, a candidate live attenuated vaccine for protection against disease caused by members of the tick-borne encephalitis virus complex: evaluation in rhesus monkeys and in mosquitoes.
Pletnev AG; Bray M; Hanley KA; Speicher J; Elkins R
J Virol; 2001 Sep; 75(17):8259-67. PubMed ID: 11483771
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of molecular strategies to develop a live dengue vaccine.
Lai CJ; Bray M; Men R; Cahour A; Chen W; Kawano H; Tadano M; Hiramatsu K; Tokimatsu I; Pletnev A; Arakai S; Shameem G; Rinaudo M
Clin Diagn Virol; 1998 Jul; 10(2-3):173-9. PubMed ID: 9741643
[TBL] [Abstract][Full Text] [Related]
7. Dengue virus type 3 vaccine candidates generated by introduction of deletions in the 3' untranslated region (3'-UTR) or by exchange of the DENV-3 3'-UTR with that of DENV-4.
Blaney JE; Sathe NS; Goddard L; Hanson CT; Romero TA; Hanley KA; Murphy BR; Whitehead SS
Vaccine; 2008 Feb; 26(6):817-28. PubMed ID: 18191005
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of St. Louis encephalitis virus/dengue virus type 4 antigenic chimeric viruses in mice and rhesus monkeys.
Blaney JE; Speicher J; Hanson CT; Sathe NS; Whitehead SS; Murphy BR; Pletnev AG
Vaccine; 2008 Aug; 26(33):4150-9. PubMed ID: 18586359
[TBL] [Abstract][Full Text] [Related]
9. Vaccine candidates derived from a novel infectious cDNA clone of an American genotype dengue virus type 2.
Blaney JE; Hanson CT; Hanley KA; Murphy BR; Whitehead SS
BMC Infect Dis; 2004 Oct; 4():39. PubMed ID: 15461822
[TBL] [Abstract][Full Text] [Related]
10. Substitution of the structural genes of dengue virus type 4 with those of type 2 results in chimeric vaccine candidates which are attenuated for mosquitoes, mice, and rhesus monkeys.
Whitehead SS; Hanley KA; Blaney JE; Gilmore LE; Elkins WR; Murphy BR
Vaccine; 2003 Oct; 21(27-30):4307-16. PubMed ID: 14505913
[TBL] [Abstract][Full Text] [Related]
11. Chimeric West Nile/dengue virus vaccine candidate: preclinical evaluation in mice, geese and monkeys for safety and immunogenicity.
Pletnev AG; Swayne DE; Speicher J; Rumyantsev AA; Murphy BR
Vaccine; 2006 Sep; 24(40-41):6392-404. PubMed ID: 16831498
[TBL] [Abstract][Full Text] [Related]
12. Monkeys immunized with intertypic chimeric dengue viruses are protected against wild-type virus challenge.
Bray M; Men R; Lai CJ
J Virol; 1996 Jun; 70(6):4162-6. PubMed ID: 8648761
[TBL] [Abstract][Full Text] [Related]
13. Chemical mutagenesis of dengue virus type 4 yields mutant viruses which are temperature sensitive in vero cells or human liver cells and attenuated in mice.
Blaney JE; Johnson DH; Firestone CY; Hanson CT; Murphy BR; Whitehead SS
J Virol; 2001 Oct; 75(20):9731-40. PubMed ID: 11559806
[TBL] [Abstract][Full Text] [Related]
14. Development of a live attenuated dengue virus vaccine using reverse genetics.
Blaney JE; Durbin AP; Murphy BR; Whitehead SS
Viral Immunol; 2006; 19(1):10-32. PubMed ID: 16553547
[TBL] [Abstract][Full Text] [Related]
15. Construction, safety, and immunogenicity in nonhuman primates of a chimeric yellow fever-dengue virus tetravalent vaccine.
Guirakhoo F; Arroyo J; Pugachev KV; Miller C; Zhang ZX; Weltzin R; Georgakopoulos K; Catalan J; Ocran S; Soike K; Ratterree M; Monath TP
J Virol; 2001 Aug; 75(16):7290-304. PubMed ID: 11462001
[TBL] [Abstract][Full Text] [Related]
16. The live attenuated dengue serotype 1 vaccine rDEN1Delta30 is safe and highly immunogenic in healthy adult volunteers.
Durbin AP; McArthur J; Marron JA; Blaney JE; Thumar B; Wanionek K; Murphy BR; Whitehead SS
Hum Vaccin; 2006; 2(4):167-73. PubMed ID: 17012875
[TBL] [Abstract][Full Text] [Related]
17. Genetically modified, live attenuated dengue virus type 3 vaccine candidates.
Blaney JE; Hanson CT; Firestone CY; Hanley KA; Murphy BR; Whitehead SS
Am J Trop Med Hyg; 2004 Dec; 71(6):811-21. PubMed ID: 15642976
[TBL] [Abstract][Full Text] [Related]
18. Molecularly engineered live-attenuated chimeric West Nile/dengue virus vaccines protect rhesus monkeys from West Nile virus.
Pletnev AG; Claire MS; Elkins R; Speicher J; Murphy BR; Chanock RM
Virology; 2003 Sep; 314(1):190-5. PubMed ID: 14517072
[TBL] [Abstract][Full Text] [Related]
19. Comparison of live and inactivated tick-borne encephalitis virus vaccines for safety, immunogenicity and efficacy in rhesus monkeys.
Rumyantsev AA; Chanock RM; Murphy BR; Pletnev AG
Vaccine; 2006 Jan; 24(2):133-43. PubMed ID: 16115704
[TBL] [Abstract][Full Text] [Related]
20. Derivation and characterization of a dengue type 1 host range-restricted mutant virus that is attenuated and highly immunogenic in monkeys.
Markoff L; Pang X; Houng Hs HS; Falgout B; Olsen R; Jones E; Polo S
J Virol; 2002 Apr; 76(7):3318-28. PubMed ID: 11884557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
